Amgen Inc. (AMGN)

Operating Profit Margin since 2005

Difficulty: Beginner

Amgen Inc., operating profit margin, long-term trends, calculation

	Operating Profit Margin	=	100	×	Operating income¹	÷	Product sales¹
Dec 31, 2005	40.33%	=	100	×	4,848	÷	12,022
Dec 31, 2006	27.71%	=	100	×	3,840	÷	13,858
Dec 31, 2007	27.81%	=	100	×	3,980	÷	14,311
Dec 31, 2008	35.50%	=	100	×	5,214	÷	14,687
Dec 31, 2009	38.37%	=	100	×	5,506	÷	14,351
Dec 31, 2010	37.82%	=	100	×	5,545	÷	14,660
Dec 31, 2011	28.19%	=	100	×	4,312	÷	15,295
Dec 31, 2012	33.52%	=	100	×	5,577	÷	16,639
Dec 31, 2013	32.25%	=	100	×	5,867	÷	18,192
Dec 31, 2014	32.03%	=	100	×	6,191	÷	19,327
Dec 31, 2015	40.44%	=	100	×	8,470	÷	20,944
Dec 31, 2016	44.74%	=	100	×	9,794	÷	21,892
Dec 31, 2017	45.76%	=	100	×	9,973	÷	21,795

¹ USD $ in millions

Source: Based on data from Amgen Inc. Annual Reports

Amgen Inc., operating profit margin, long-term trends, comparison to competitors

	Amgen Inc.	Abbott Laboratories	AbbVie Inc.	Allergan PLC	Biogen Inc.	Celgene Corp.	Gilead Sciences Inc.	Regeneron Pharmaceuticals Inc.
Dec 31, 2005	40.33%	19.53%	–%	13.27%	9.74%	18.76%	61.41%	-187.97%
Dec 31, 2006	27.71%	9.09%	–%	-21.33%	16.40%	21.52%	-29.32%	-169.68%
Dec 31, 2007	27.81%	17.67%	–%	10.24%	24.59%	32.69%	57.98%	-91.55%
Dec 31, 2008	35.50%	19.28%	–%	14.12%	29.62%	-68.50%	52.68%	-37.67%
Dec 31, 2009	38.37%	20.27%	–%	13.75%	29.59%	32.78%	54.55%	-19.54%
Dec 31, 2010	37.82%	17.31%	–%	8.56%	26.48%	28.21%	53.62%	-21.23%
Dec 31, 2011	28.19%	14.81%	–%	11.70%	34.16%	30.70%	46.77%	-46.02%
Dec 31, 2012	33.52%	20.28%	31.65%	5.42%	33.64%	32.43%	42.67%	33.20%
Dec 31, 2013	32.25%	12.03%	30.14%	-4.88%	36.29%	28.43%	41.87%	36.11%
Dec 31, 2014	32.03%	12.84%	17.09%	-9.71%	40.94%	33.30%	62.37%	29.74%
Dec 31, 2015	40.44%	14.05%	32.97%	-20.00%	45.44%	24.61%	69.03%	30.51%
Dec 31, 2016	44.74%	15.27%	36.60%	-12.53%	44.99%	28.31%	58.87%	27.38%
Dec 31, 2017	45.76%	6.30%	33.99%	-37.15%	43.54%	36.28%	55.04%	35.41%

Source: Based on data from Amgen Inc. Annual Reports